Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN-004 Phase 2 Pneumococcal Challenge Study
NCT02116998Phase 2Completed
- Sponsor
- Genocea Biosciences
- Start
- Sep 2014
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEN-004 in pneumococcal infection, sponsored by Genocea Biosciences. Started Sep 2014; status: completed.
02
Drugs
GEN-004
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02116998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116998.